Atlas Trials

SAP Depleter Dose Assessment Study in Patients

Clinical trial NCT01406314 · COMPLETED

Trial details

NCT number
NCT01406314
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Amyloidosis
Start date
2011-10-13
Primary completion
2012-11-14
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.